Skip to main content
. 2013 Sep 25;28(10):1474–1481. doi: 10.3346/jkms.2013.28.10.1474

Table 3.

Pre and post-treatment serum concentration and urinary excretion of sFas in proliferative and non-proliferative glomerulonephritis (GN)

graphic file with name jkms-28-1474-i003.jpg

Differences were considered significant for P < 0.05 (Kruskal-Wallis ANOVA). *Proliferative GN before vs after treatment; Proliferative GN before treatment vs Non-proliferave GN after treatment; Proliferative GN after treatment vs Non-proliferative GN before treatment; §Non-proliferative GN before vs after treatment.